Canine epidermal neural crest stem cells: Characterization and potential as therapy candidate for a large animal model of spinal cord injury

Barbara Gericota, Joseph S Anderson, Gaela Mitchell, Dori L Borjesson, Beverly Sturges, Jan Nolta, Maya Sieber-Blum

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The discovery of multipotent neural crest-derived stem cells, named epidermal neural crest stem cells (EPI-NCSC), that persist postnatally in an easy-to-access location-the bulge of hair follicles-opens a spectrum of novel opportunities for patient-specific therapies. We present a detailed characterization of canine EPI-NCSC (cEPI-NCSC) from multiple dog breeds and protocols for their isolation and ex vivo expansion. Furthermore, we provide novel tools for research in canines, which currently are still scarce. In analogy to human and mouse EPI-NCSC, the neural crest origin of cEPI-NCSC is shown by their expression of the neural crest stem cell molecular signature and other neural crest-characteristic genes. Similar to human EPI-NCSC, cEPI-NCSC also expressed pluripotency genes. We demonstrated that cEPI-NCSC can generate all major neural crest derivatives. In vitro clonal analyses established multipotency and self-renewal ability of cEPI-NCSC, establishing cEPI-NCSC as multipotent somatic stem cells. A critical analysis of the literature on canine spinal cord injury (SCI) showed the need for novel treatments and suggested that cEPI-NCSC represent viable candidates for cell-based therapies in dog SCI, particularly for chondrodystrophic dogs. This notion is supported by the close ontological relationship between neural crest stem cells and spinal cord stem cells. Thus, cEPI-NCSC promise to offer not only a potential treatment for canines but also an attractive and realistic large animal model for human SCI. Taken together, we provide the groundwork for the development of a novel cell-based therapy for a condition with extremely poor prognosis and no available effective treatment.

Original languageEnglish (US)
Pages (from-to)334-345
Number of pages12
JournalStem cells translational medicine
Volume3
Issue number3
DOIs
StatePublished - 2014

Fingerprint

Neural Stem Cells
Neural Crest
Spinal Cord Injuries
Canidae
Animal Models
Therapeutics
Dogs
Cell- and Tissue-Based Therapy
Stem Cells
Multipotent Stem Cells
Adult Stem Cells
Hair Follicle
Genes
Spinal Cord

Keywords

  • Adult stem cells
  • Canine epidermal neural crest stem cells
  • cEPI-NCSC
  • Dog model
  • EPI-NCSC
  • Hair follicle
  • Neural crest
  • Spinal cord injury

ASJC Scopus subject areas

  • Cell Biology
  • Developmental Biology

Cite this

Canine epidermal neural crest stem cells : Characterization and potential as therapy candidate for a large animal model of spinal cord injury. / Gericota, Barbara; Anderson, Joseph S; Mitchell, Gaela; Borjesson, Dori L; Sturges, Beverly; Nolta, Jan; Sieber-Blum, Maya.

In: Stem cells translational medicine, Vol. 3, No. 3, 2014, p. 334-345.

Research output: Contribution to journalArticle

@article{347167e9c0464c879f8b5d5820a6b9f8,
title = "Canine epidermal neural crest stem cells: Characterization and potential as therapy candidate for a large animal model of spinal cord injury",
abstract = "The discovery of multipotent neural crest-derived stem cells, named epidermal neural crest stem cells (EPI-NCSC), that persist postnatally in an easy-to-access location-the bulge of hair follicles-opens a spectrum of novel opportunities for patient-specific therapies. We present a detailed characterization of canine EPI-NCSC (cEPI-NCSC) from multiple dog breeds and protocols for their isolation and ex vivo expansion. Furthermore, we provide novel tools for research in canines, which currently are still scarce. In analogy to human and mouse EPI-NCSC, the neural crest origin of cEPI-NCSC is shown by their expression of the neural crest stem cell molecular signature and other neural crest-characteristic genes. Similar to human EPI-NCSC, cEPI-NCSC also expressed pluripotency genes. We demonstrated that cEPI-NCSC can generate all major neural crest derivatives. In vitro clonal analyses established multipotency and self-renewal ability of cEPI-NCSC, establishing cEPI-NCSC as multipotent somatic stem cells. A critical analysis of the literature on canine spinal cord injury (SCI) showed the need for novel treatments and suggested that cEPI-NCSC represent viable candidates for cell-based therapies in dog SCI, particularly for chondrodystrophic dogs. This notion is supported by the close ontological relationship between neural crest stem cells and spinal cord stem cells. Thus, cEPI-NCSC promise to offer not only a potential treatment for canines but also an attractive and realistic large animal model for human SCI. Taken together, we provide the groundwork for the development of a novel cell-based therapy for a condition with extremely poor prognosis and no available effective treatment.",
keywords = "Adult stem cells, Canine epidermal neural crest stem cells, cEPI-NCSC, Dog model, EPI-NCSC, Hair follicle, Neural crest, Spinal cord injury",
author = "Barbara Gericota and Anderson, {Joseph S} and Gaela Mitchell and Borjesson, {Dori L} and Beverly Sturges and Jan Nolta and Maya Sieber-Blum",
year = "2014",
doi = "10.5966/sctm.2013-0129",
language = "English (US)",
volume = "3",
pages = "334--345",
journal = "Stem cells translational medicine",
issn = "2157-6564",
publisher = "AlphaMed Press",
number = "3",

}

TY - JOUR

T1 - Canine epidermal neural crest stem cells

T2 - Characterization and potential as therapy candidate for a large animal model of spinal cord injury

AU - Gericota, Barbara

AU - Anderson, Joseph S

AU - Mitchell, Gaela

AU - Borjesson, Dori L

AU - Sturges, Beverly

AU - Nolta, Jan

AU - Sieber-Blum, Maya

PY - 2014

Y1 - 2014

N2 - The discovery of multipotent neural crest-derived stem cells, named epidermal neural crest stem cells (EPI-NCSC), that persist postnatally in an easy-to-access location-the bulge of hair follicles-opens a spectrum of novel opportunities for patient-specific therapies. We present a detailed characterization of canine EPI-NCSC (cEPI-NCSC) from multiple dog breeds and protocols for their isolation and ex vivo expansion. Furthermore, we provide novel tools for research in canines, which currently are still scarce. In analogy to human and mouse EPI-NCSC, the neural crest origin of cEPI-NCSC is shown by their expression of the neural crest stem cell molecular signature and other neural crest-characteristic genes. Similar to human EPI-NCSC, cEPI-NCSC also expressed pluripotency genes. We demonstrated that cEPI-NCSC can generate all major neural crest derivatives. In vitro clonal analyses established multipotency and self-renewal ability of cEPI-NCSC, establishing cEPI-NCSC as multipotent somatic stem cells. A critical analysis of the literature on canine spinal cord injury (SCI) showed the need for novel treatments and suggested that cEPI-NCSC represent viable candidates for cell-based therapies in dog SCI, particularly for chondrodystrophic dogs. This notion is supported by the close ontological relationship between neural crest stem cells and spinal cord stem cells. Thus, cEPI-NCSC promise to offer not only a potential treatment for canines but also an attractive and realistic large animal model for human SCI. Taken together, we provide the groundwork for the development of a novel cell-based therapy for a condition with extremely poor prognosis and no available effective treatment.

AB - The discovery of multipotent neural crest-derived stem cells, named epidermal neural crest stem cells (EPI-NCSC), that persist postnatally in an easy-to-access location-the bulge of hair follicles-opens a spectrum of novel opportunities for patient-specific therapies. We present a detailed characterization of canine EPI-NCSC (cEPI-NCSC) from multiple dog breeds and protocols for their isolation and ex vivo expansion. Furthermore, we provide novel tools for research in canines, which currently are still scarce. In analogy to human and mouse EPI-NCSC, the neural crest origin of cEPI-NCSC is shown by their expression of the neural crest stem cell molecular signature and other neural crest-characteristic genes. Similar to human EPI-NCSC, cEPI-NCSC also expressed pluripotency genes. We demonstrated that cEPI-NCSC can generate all major neural crest derivatives. In vitro clonal analyses established multipotency and self-renewal ability of cEPI-NCSC, establishing cEPI-NCSC as multipotent somatic stem cells. A critical analysis of the literature on canine spinal cord injury (SCI) showed the need for novel treatments and suggested that cEPI-NCSC represent viable candidates for cell-based therapies in dog SCI, particularly for chondrodystrophic dogs. This notion is supported by the close ontological relationship between neural crest stem cells and spinal cord stem cells. Thus, cEPI-NCSC promise to offer not only a potential treatment for canines but also an attractive and realistic large animal model for human SCI. Taken together, we provide the groundwork for the development of a novel cell-based therapy for a condition with extremely poor prognosis and no available effective treatment.

KW - Adult stem cells

KW - Canine epidermal neural crest stem cells

KW - cEPI-NCSC

KW - Dog model

KW - EPI-NCSC

KW - Hair follicle

KW - Neural crest

KW - Spinal cord injury

UR - http://www.scopus.com/inward/record.url?scp=84896264220&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896264220&partnerID=8YFLogxK

U2 - 10.5966/sctm.2013-0129

DO - 10.5966/sctm.2013-0129

M3 - Article

C2 - 24443004

AN - SCOPUS:84896264220

VL - 3

SP - 334

EP - 345

JO - Stem cells translational medicine

JF - Stem cells translational medicine

SN - 2157-6564

IS - 3

ER -